These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7371359)

  • 1. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome-dependent degradation of intracellular carbamylated proteins.
    Desmons A; Okwieka A; Doué M; Gorisse L; Vuiblet V; Pietrement C; Gillery P; Jaisson S
    Aging (Albany NY); 2019 Jun; 11(11):3624-3638. PubMed ID: 31170093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evalution of in vitro effect of flavonoids on human low-density lipoprotein carbamylation.
    Ghaffari MA; Shanaki M
    Iran J Pharm Res; 2010; 9(1):67-74. PubMed ID: 24363709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Carbamylation in Chronic Kidney Disease and Dialysis.
    Long J; Vela Parada X; Kalim S
    Adv Clin Chem; 2018; 87():37-67. PubMed ID: 30342712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients.
    Lenglet A; Jaisson S; Gillery P; El Balkhi S; Liabeuf S; Massy ZA
    Amino Acids; 2023 Oct; 55(10):1455-1460. PubMed ID: 37532908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylation in Uremia.
    Hostetter T
    J Am Soc Nephrol; 2023 May; 34(5):731-732. PubMed ID: 37022135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
    Battle S; Gogonea V; Willard B; Wang Z; Fu X; Huang Y; Graham LM; Cameron SJ; DiDonato JA; Crabb JW; Hazen SL
    J Biol Chem; 2022 Apr; 298(4):101832. PubMed ID: 35304099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avenues for post-translational protein modification prevention and therapy.
    Tang M; Kalim S
    Mol Aspects Med; 2022 Aug; 86():101083. PubMed ID: 35227517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.
    Trejo-Zambrano MI; Gómez-Bañuelos E; Andrade F
    Antioxid Redox Signal; 2022 Mar; 36(7-9):389-409. PubMed ID: 33906423
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors.
    André C; Choukroun G; Bennis Y; Kamel S; Lemaire-Hurtel AS; Masmoudi K; Bodeau S; Liabeuf S
    Nephrol Dial Transplant; 2022 Oct; 37(11):2284-2292. PubMed ID: 33783543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.
    Kalim S; Berg AH; Karumanchi SA; Thadhani R; Allegretti AS; Nigwekar S; Zhao S; Srivastava A; Raj D; Deo R; Frydrych A; Chen J; Sondheimer J; Shafi T; Weir M; Lash JP;
    Nephrol Dial Transplant; 2021 Dec; 37(1):139-147. PubMed ID: 33661286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning.
    Schindler L; Dickerhof N; Hampton MB; Bernhagen J
    Redox Biol; 2018 May; 15():135-142. PubMed ID: 29247897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients.
    Chen YS; Liu ZQ; Chen R; Wang L; Huang L; Zhu X; Zhou TY; Lu W; Ma P
    Acta Pharmacol Sin; 2017 Aug; 38(8):1195-1204. PubMed ID: 28552913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
    J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein carbamylation in kidney disease: pathogenesis and clinical implications.
    Kalim S; Karumanchi SA; Thadhani RI; Berg AH
    Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
    Kalim S; Tamez H; Wenger J; Ankers E; Trottier CA; Deferio JJ; Berg AH; Karumanchi SA; Thadhani RI
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1927-34. PubMed ID: 23970130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.
    Tang WH; Shrestha K; Wang Z; Borowski AG; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2013 Apr; 19(4):219-24. PubMed ID: 23582087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.
    Mydel P; Wang Z; Brisslert M; Hellvard A; Dahlberg LE; Hazen SL; Bokarewa M
    J Immunol; 2010 Jun; 184(12):6882-90. PubMed ID: 20488785
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.